finasteride has been researched along with Neoplasms in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 5 (62.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bratoeff, E; Cabeza, M; Heuze, Y; Ramírez-Apan, T; Sánchez, A; Silva-Ortiz, AV; Soriano, J | 1 |
| Fu, Y; Lin, Y; Liu, Y; Pan, T; Wu, K; Zhang, H; Zhang, S; Zhang, X; Zhou, J | 1 |
| Brodell, LA; Mercurio, MG | 1 |
| Bergstrom, KG | 1 |
| Dunn, BK; Greenwald, P; Umar, A | 1 |
| Zielinski, SL | 1 |
| Hampton, T | 1 |
| Kardinal, CG | 1 |
2 review(s) available for finasteride and Neoplasms
| Article | Year |
|---|---|
Hirsutism: Diagnosis and management.
Topics: 5-alpha Reductase Inhibitors; Adrenal Hyperplasia, Congenital; Causality; Contraceptives, Oral; Diagnosis, Differential; Eflornithine; Female; Finasteride; Hair Removal; Hirsutism; Humans; Hypoglycemic Agents; Laser Therapy; Metformin; Mineralocorticoid Receptor Antagonists; Neoplasms; Ornithine Decarboxylase Inhibitors; Polycystic Ovary Syndrome; Spironolactone | 2010 |
Future directions in cancer prevention.
Topics: Aromatase Inhibitors; Azasteroids; Breast Neoplasms; Cancer Vaccines; Diet; Dutasteride; Female; Finasteride; Humans; Immunotherapy; Life Style; Male; Motor Activity; Neoplasms; Nicotiana; Obesity; Prostatic Neoplasms; Selective Estrogen Receptor Modulators; Vaccines | 2012 |
6 other study(ies) available for finasteride and Neoplasms
| Article | Year |
|---|---|
Synthesis and activity of novel 16-dehydropregnenolone acetate derivatives as inhibitors of type 1 5α-reductase and on cancer cell line SK-LU-1.
Topics: 5-alpha Reductase Inhibitors; Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cholestenone 5 alpha-Reductase; Humans; Male; Mesocricetus; Neoplasms; Pregnenolone; Rats | 2015 |
Finasteride Enhances the Generation of Human Myeloid-Derived Suppressor Cells by Up-Regulating the COX2/PGE2 Pathway.
Topics: Autoimmunity; Cell Line; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Finasteride; Humans; Immune System Diseases; Immune Tolerance; Indomethacin; Myeloid-Derived Suppressor Cells; Neoplasms; Signal Transduction | 2016 |
What's new in androgenetic alopecia: approvals, long-term safety data, cancer risk and treatment options for women.
Topics: Alopecia; Azasteroids; Drug Approval; Drug-Related Side Effects and Adverse Reactions; Dutasteride; Female; Finasteride; Humans; Male; Minoxidil; Neoplasms; Risk Factors; Time Factors | 2011 |
Despite positive studies, popularity of chemoprevention drugs increasing slowly.
Topics: Adenomatous Polyposis Coli; Androgen Antagonists; Anti-Inflammatory Agents, Non-Steroidal; Anticarcinogenic Agents; Antineoplastic Agents, Hormonal; Breast Neoplasms; Celecoxib; Cell Transformation, Neoplastic; Clinical Trials as Topic; Cost-Benefit Analysis; Drug Prescriptions; Female; Finasteride; Humans; Male; Neoplasms; Prostatic Neoplasms; Pyrazoles; Sulfonamides; Tamoxifen; United States | 2004 |
Clinical trials point to complexities of chemoprevention for cancer.
Topics: Aspirin; Breast Neoplasms; Clinical Trials as Topic; Diet; Dihydrotestosterone; Female; Finasteride; Humans; Male; Neoplasms; Prostatic Neoplasms; Selective Estrogen Receptor Modulators; Tamoxifen; Vitamin E | 2005 |
Cancer. A potentially preventable disease.
Topics: Aspirin; Environmental Exposure; Female; Finasteride; Humans; Isotretinoin; Life Style; Male; Middle Aged; Neoplasms; Risk Factors; Tamoxifen | 1995 |